FDG-PET for detecting local tumor recurrence of ablated liver metastases: a diagnostic meta-analysis

被引：10

作者：

Poulou, Loukia S. ^{[1
]}

Ziakas, Panayiotis D. ^{[2
]}

Ziogas, Dimitrios C. ^{[2
]}

Doxani, Chrysoula ^{[3
]}

Xyla, Vassilia ^{[2
]}

Vakrinos, George ^{[1
]}

Voulgarelis, Michael ^{[2
]}

Thanos, Loukas ^{[1
]}

机构：

[1] Gen Hosp Chest Dis Sotiria, Dept Med Imaging & Intervent Radiol, Athens 11527, Greece

[2] Univ Athens, Sch Med, Dept Pathophysiol, Athens 11528, Greece

[3] Univ Thessaly, Sch Med, Dept Biomath, Larisa, Greece

来源：

BIOMARKERS | 2012年 / 17卷 / 06期

关键词：

Radiofrequency ablation; positron emission tomography; metastasis; meta-analysis; POSITRON-EMISSION-TOMOGRAPHY; RADIOFREQUENCY THERMAL ABLATION; COLORECTAL-CANCER; HEPATIC-TUMORS; FOLLOW-UP; CT; MANAGEMENT; TISSUE; PERFORMANCE; CARCINOMA;

D O I：

10.3109/1354750X.2012.699553

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Context: Scanty reports have focused on FDG-PET after radiofrequency ablation (RFA), for recurrence of hepatic metastases. Objective: To assess FDG-PET diagnostic accuracy on detection of recurrent hepatic lesions. Methods: After a comprehensive search of PubMed and EMBASE, we performed a patient-based diagnostic meta-analysis of post-RFA FDG-PET. Results: Across nine included articles, independent, random-effects sensitivity and specificity were 0.73(0.50-0.88) and 0.85(0.72-0.93), respectively. A symmetrical SROC curve was produced with no significant heterogeneity. Specificity was optimal for surgical RFA and colorectal origin of metastases. Conclusion: Synthesis of published evidence suggests PET/CT as an appropriate tool for optimizing post-ablation follow-up.

引用

页码：532 / 538

页数：7

共 47 条

[1] Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: Correlation with histopathologic and CT findings [J].

Abdel-Nabi, H ;

Doerr, RJ ;

Lamonica, DM ;

Cronin, VR ;

Galantowicz, P ;

Carbone, GM ;

Spaulding, MB .

RADIOLOGY, 1998, 206 (03) :755-760

[2] FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation [J].

Anderson, GS ;

Brinkmann, F ;

Soulen, MC ;

Alavi, A ;

Zhuang, HM .

CLINICAL NUCLEAR MEDICINE, 2003, 28 (03) :192-197

[3]

[Anonymous], 2002, BAYES LIB DIAGNOSTIC

[4]

Antoch G, 2005, J NUCL MED, V46, P520

[5] Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence [J].

Ayav, Ahmet ;

Germain, Adeline ;

Marchal, Frederic ;

Tierris, Ioannis ;

Laurent, Valerie ;

Bazin, Christophe ;

Yuan, Yufeng ;

Robert, Laurence ;

Brunaud, Laurent ;

Bresler, Laurent .

AMERICAN JOURNAL OF SURGERY, 2010, 200 (04) :435-439

[6] Colorectal liver metastases: CT, MR imaging, and PET for diagnosis - Meta-analysis [J].

Bipat, S ;

van Leeuwen, MS ;

Comans, EFI ;

Pijl, MEJ ;

Bossuyt, PMM ;

Zwinderman, AH ;

Stoker, J .

RADIOLOGY, 2005, 237 (01) :123-131

[7] Results of radio frequency ablation of primary and secondary liver tumors: Long-term follow-up with computed tomography and positron emission tomography-18F-deoxyfluoroglucose scanning [J].

Blokhuis, TJ ;

van der Schaaf, NC ;

van den Tol, MP ;

Comans, EFI ;

Manoliu, RA ;

van der Sijp, JRM .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 :93-97

[8] Radiofrequency ablation of malignant liver tumors [J].

Curley, SA .

ONCOLOGIST, 2001, 6 (01) :14-23

[9]

Delbeke D, 1997, J NUCL MED, V38, P1196

[10] [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases [J].

Donckier, V ;

Van Laethem, JL ;

Goldman, S ;

Van Gansbeke, D ;

Feron, P ;

Ickx, B ;

Wikler, D ;

Gelin, M .

JOURNAL OF SURGICAL ONCOLOGY, 2003, 84 (04) :215-223

← 1 2 3 4 5 →